Results 141 to 150 of about 18,455 (220)

Considerations for Establishing Peptide Receptor Radionuclide Therapy: A Nationally Coordinated, Collaborative, and Equitable Service for New Zealand. [PDF]

open access: yesWorld J Nucl Med
Steyn R   +13 more
europepmc   +1 more source

Fibrosis markers as prognostic markers of decline in kidney function in patients with neuroendocrine neoplasms undergoing peptide receptor radionuclide therapy. [PDF]

open access: yesFront Endocrinol (Lausanne)
Stemann Lau T   +7 more
europepmc   +1 more source

Multicycle Dosimetric Behavior and Dose-Effect Relationships in [<sup>177</sup>Lu]Lu-DOTATATE Peptide Receptor Radionuclide Therapy. [PDF]

open access: yesJ Nucl Med
Kayal G   +7 more
europepmc   +1 more source

An ACTH-Producing Neuroendocrine Tumor: Clinical Course of Multidisciplinary Therapy Including Peptide Receptor Radionuclide Therapy - A Case Report. [PDF]

open access: yesCase Rep Oncol
Koizumi T   +10 more
europepmc   +1 more source

Treatment planning for molecular radiotherapy: potential and prospects [PDF]

open access: yes, 2017
Aldridge, Matt   +14 more
core  

Somatostatin analogs: Future directions [PDF]

open access: yes, 1996
Herder, W.W. (Wouter) de   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy